Investor

The company currently sells connected wearables and smart monitors to consumers, but said that it will be seeking FDA authorization for new products with broader indications and telehealth capabilities down the line.

The fund will be zeroing in on sensing tech, data analytics, remote patient monitoring and population health.

Also: docdok.health rolling out COVID-19 vaccination study app; IBM Watson Health partners with Humana.

Also: Insightin Health scores $12M for its engagement platform and Rhino Health raises $5M in seed funding for AI tech. 

MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.

The company attributes volume growth, new patient additions and increasing awareness of real-time continuous glucose monitoring to its revenue growth.   

The company said that its platform is currently in use among more than 4,800 emergency communications centers across the U.S.

This is the third funding round for Modern in about 13 months, and propels the San Francisco company to unicorn status.

The company upwardly revised its IPO twice since filing with the SEC last month.

During COVID-19 the company has added a vaccine finder feature and a telehealth scheduler.